Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBT Margin (2020 - 2025)

Bio Essence (BIOE) has 6 years of EBT Margin data on record, last reported at 9.5% in Q3 2025.

  • For Q3 2025, EBT Margin rose 90006.0% year-over-year to 9.5%; the TTM value through Sep 2025 reached 38.77%, up 118443.0%, while the annual FY2024 figure was 483.09%, 41002.0% down from the prior year.
  • EBT Margin reached 9.5% in Q3 2025 per BIOE's latest filing, down from 23.41% in the prior quarter.
  • Across five years, EBT Margin topped out at 436.81% in Q4 2024 and bottomed at 927.27% in Q1 2025.
  • Average EBT Margin over 5 years is 141.9%, with a median of 69.32% recorded in 2021.
  • The widest YoY moves for EBT Margin: up 90006bps in 2025, down -84734bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 42.54% in 2021, then grew by 3bps to 41.19% in 2022, then surged by 92bps to 3.13% in 2023, then skyrocketed by 14044bps to 436.81% in 2024, then plummeted by -98bps to 9.5% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 9.5% in Q3 2025, 23.41% in Q2 2025, and 927.27% in Q1 2025.